Synopses & Reviews
The last twenty-five years have witnessed an explosion of knowledge about the influence of brain biochemistry on mood and behavior and about pharmacological approaches to treating mental and emotional disorders. A substantial portion of patients seen in clinical practice are taking some medication or might usefully be advised to do so. But many clinical psychologists, social workers, and counselors need additional information in order to better treat patients already on medication, know when and to whom to refer new patients for psychiatric consultation, and work collaboratively with psychiatrists when appropriate. andlt;BRandgt; Michael J. Gitlin's indispensable first edition of andlt;Iandgt;The Psychotherapists Guide to Psychopharmacologyandlt;/Iandgt; has now been updated and revised -- this new second edition now reflects major changes that have influenced the clinical arena in the last five years such as the recent release of DSM-IV and the domination of the psychopharmacological field by the selective serotonin reuptake inhibitors, such as fluoxetine (Prozac). andlt;Iandgt;The Psychotherapists Guide to Psychopharmacology, Second Editionandlt;/Iandgt; also now includes coverage of attention deficit/hyperactivity disorder and contains updated sections on the new antipsychotics for schizophrenia and the increased use of anticonvulsant mood stabilizers for bipolar disorder. The book also includes other significant changes that have influenced the field over the last few years, such as brain imaging studies, research in obsessive compulsive disorder and social phobia, and such prominent topics in women's health as pregnancy, PMS, postpartum disorders, and breast feeding. andlt;BRandgt; This revision of an already established guide will again be an essential reference for all nonmedical professionals involved in treating mental and emotional disorders.
Review
Stanley R. Grahame, Ph.D. Clinical Director, Fifth Avenue Center for Counseling and Psychotherapy Director of Training, Greenwich Institute for Psychoanalytic Studies A concise, comprehensive review of the field of psychopharmacology which succeeds in communicating a mass of relevant data in an easily understandable text without talking down to the nonmedical psychotherapist. It is a triumph in communication of what every therapist should know about...patients who are receiving medication, who should be receiving medication, and who should not be receiving medication. The best book of its kind to date.
Review
Lester Grinspoon, M.D. Associate Professor of Psychiatry, Harvard Medical School Editor, andlt;Iandgt;Harvard Medical School Mental Health Letterandlt;/Iandgt; Since the introduction of chlorpromazine in 1953, a biological revolution has confronted psychotherapists with a vast array of medications which can enhance their effectiveness in treating a large variety of mental disorders. The practice of psychotherapy now requires an understanding of these drugs, including their indications, mechanisms of action, side effects, and especially the complex relationship between drug treatment and psychotherapy. For that purpose Gitlin's well-written, thorough, and comprehensive book is the best I have seen -- a text that will be useful not only to therapists without medical training but also to the psychopharmacologically sophisticated.
Review
Robert O. Pasnau, M.D. Professor of Psychiatry, University of California, Los Angeles Chief of Staff, Neuropsychiatric Institute Hospital Assistant Dean, School of Medicine It is extremely useful for those psychiatrists, like me, who as psychotherapists are becoming increasingly convinced that combined pharmacology and psychotherapy is the treatment of choice of the majority of our patients. Most of my patients want to know why and how medications work, and they are becoming increasingly knowledgeable about side effects and dependency.
Review
Judith Marks Mishne, D.S.W. Professor, New York University School of Social Work This most readable, jargon-free text is clear, astute, and bridges the split between those physicians who prescribe medication and those therapists who do not....Dr. Gitlin's dual knowledge base and his respect for both methods of intervention are clear, as he demonstrates comfort with the split treatment model and collegial regard for the nonmedical clinician. This text is a must as a clinical guide for the nonphysician therapist.
Synopsis
The last twenty-five years have witnessed an explosion of knowledge about the influence of brain biochemistry on mood and behavior and about pharmacological approaches to treating mental and emotional disorders. A substantial portion of patients seen in clinical practice are taking some medication or might usefully be advised to do so. But many clinical psychologists, social workers, and counselors need additional information in order to better treat patients already on medication, know when and to whom to refer new patients for psychiatric consultation, and work collaboratively with psychiatrists when appropriate.
Michael J. Gitlin's indispensable first edition of The Psychotherapists Guide to Psychopharmacology has now been updated and revised -- this new second edition now reflects major changes that have influenced the clinical arena in the last five years such as the recent release of DSM-IV and the domination of the psychopharmacological field by the selective serotonin reuptake inhibitors, such as fluoxetine (Prozac). The Psychotherapists Guide to Psychopharmacology, Second Edition also now includes coverage of attention deficit/hyperactivity disorder and contains updated sections on the new antipsychotics for schizophrenia and the increased use of anticonvulsant mood stabilizers for bipolar disorder. The book also includes other significant changes that have influenced the field over the last few years, such as brain imaging studies, research in obsessive compulsive disorder and social phobia, and such prominent topics in women's health as pregnancy, PMS, postpartum disorders, and breast feeding.
This revision of an already established guide will again be an essential reference for all nonmedical professionals involved in treating mental and emotional disorders.
Description
Includes bibliographical references (p. 473-508) and index.
About the Author
andlt;Bandgt;Michael J. Gitlin, M.D.andlt;/Bandgt; is an authority on psychopharmacology who has published numerous articles. He is Clinical Professor of Psychiatry and Director of the Affective Disorders Program and of the General Outpatient Clinic at the UCLA Neuropsychiatric Hospital.
Table of Contents
andlt;BRandgt;andlt;Bandgt;Contentsandlt;/Bandgt;andlt;BRandgt;andlt;BRandgt;List of Illustrations and Tablesandlt;BRandgt;andlt;BRandgt;Prefaceandlt;BRandgt;andlt;BRandgt;Acknowledgmentsandlt;BRandgt;andlt;BRandgt;SECTION ONEandlt;BRandgt;andlt;BRandgt;andlt;Bandgt;1. Diagnosis and Treatment: Basic Principlesandlt;/Bandgt;andlt;BRandgt;andlt;BRandgt;Descriptive Psychiatry and DSM-IVandlt;BRandgt;andlt;BRandgt;Pharmacotherapy and Its Implications for Other Therapiesandlt;BRandgt;andlt;BRandgt;Evaluating Treatments: The Meaning of the Word Effectiveandlt;BRandgt;andlt;BRandgt;Goals of Pharmacotherapyandlt;BRandgt;andlt;BRandgt;Some General Issues in Psychopharmacological Treatmentandlt;BRandgt;andlt;BRandgt;FDA Approval and PDR Dosesandlt;BRandgt;andlt;BRandgt;Polypharmacyandlt;BRandgt;andlt;BRandgt;Practice Guidelinesandlt;BRandgt;andlt;BRandgt;Who Should Have a Medication Consultation?andlt;BRandgt;andlt;BRandgt;SECTION TWOandlt;BRandgt;andlt;BRandgt;andlt;Bandgt;2. Biological Basis of Psychopharmacologyandlt;/Bandgt;andlt;BRandgt;andlt;BRandgt;Neurotransmission: How Cells Communicateandlt;BRandgt;andlt;BRandgt;How Medications Workandlt;BRandgt;andlt;BRandgt;Neurotransmitters That Help Regulate Mood and Behaviorandlt;BRandgt;andlt;BRandgt;Neuroimaging Techniques in Psychiatric Disordersandlt;BRandgt;andlt;BRandgt;Biological Hypotheses of the Major Psychiatric Disordersandlt;BRandgt;andlt;BRandgt;Mood Disordersandlt;BRandgt;andlt;BRandgt;Schizophreniaandlt;BRandgt;andlt;BRandgt;Anxiety Disordersandlt;BRandgt;andlt;BRandgt;SECTION THREEandlt;BRandgt;andlt;BRandgt;andlt;Bandgt;3. Mood Disordersandlt;/Bandgt;andlt;BRandgt;andlt;BRandgt;Diagnosisandlt;BRandgt;andlt;BRandgt;Major Depressionandlt;BRandgt;andlt;BRandgt;Subtypes of Major Depressive Disorderandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Melancholic Depressionandlt;BRandgt;andlt;BRandgt;Major Depression with Psychotic Featuresandlt;BRandgt;andlt;BRandgt;Atypical Depressionandlt;BRandgt;andlt;BRandgt;Seasonal Depressionandlt;BRandgt;andlt;BRandgt;Postpartum Depressionandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Bipolar Disorderandlt;BRandgt;andlt;BRandgt;Natural History, Epidemiology, and Geneticsandlt;BRandgt;andlt;BRandgt;Presentations of Mild Mood Disordersandlt;BRandgt;andlt;BRandgt;Dysthymiaandlt;BRandgt;andlt;BRandgt;Cyclothymiaandlt;BRandgt;andlt;BRandgt;Recurrent Brief Depressions and Minor Depressionsandlt;BRandgt;andlt;BRandgt;Medical Differential Diagnosis and Evaluationandlt;BRandgt;andlt;BRandgt;Medications Causing Depressionandlt;BRandgt;andlt;BRandgt;Laboratory Evaluationandlt;BRandgt;andlt;BRandgt;Psychiatric Differential Diagnosisandlt;BRandgt;andlt;BRandgt;Depressionandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Mourningandlt;BRandgt;andlt;BRandgt;Demoralizationandlt;BRandgt;andlt;BRandgt;Adjustment Disorder with Depressed Moodandlt;BRandgt;andlt;BRandgt;Premenstrual Syndromeandlt;BRandgt;andlt;BRandgt;Dementia Syndromesandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Maniaandlt;BRandgt;andlt;BRandgt;Psychopharmacological Treatmentandlt;BRandgt;andlt;BRandgt;Pharmacotherapy of Major Depression (Unipolar Depression)andlt;BRandgt;andlt;BRandgt;First-Line Agentsandlt;BRandgt;andlt;BRandgt;Second-Line Agentsandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Monoamine Oxidase (MAO) Inhibitorsandlt;BRandgt;andlt;BRandgt;Electroconvulsive Treatmentandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Other Optionsandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Mood Stabilizersandlt;BRandgt;andlt;BRandgt;Stimulantsandlt;BRandgt;andlt;BRandgt;Light Therapyandlt;BRandgt;andlt;BRandgt;Antianxiety Agentsandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Strategies Used in Treatment-Resistant Depressionsandlt;BRandgt;andlt;BRandgt;Continuation Treatment of Unipolar Depressionandlt;BRandgt;andlt;BRandgt;Maintenance Treatment of Unipolar Disorderandlt;BRandgt;andlt;BRandgt;Pharmacotherapy of Bipolar Disorderandlt;BRandgt;andlt;BRandgt;Treatment of Acute Manic Episodesandlt;BRandgt;andlt;BRandgt;Continuation Treatment of Manic or Hypomanic Episodesandlt;BRandgt;andlt;BRandgt;Bipolar Depression -- Acute and Continuation Treatmentandlt;BRandgt;andlt;BRandgt;Maintenance Treatment of Bipolar Disorderandlt;BRandgt;andlt;BRandgt;andlt;Bandgt;4. Anxiety Disorders and Insomniaandlt;/Bandgt;andlt;BRandgt;andlt;BRandgt;Diagnosisandlt;BRandgt;andlt;BRandgt;Natural History, Epidemiology, and Geneticsandlt;BRandgt;andlt;BRandgt;Medical Differential Diagnosisandlt;BRandgt;andlt;BRandgt;Medical and Laboratory Evaluationandlt;BRandgt;andlt;BRandgt;Psychiatric Differential Diagnosisandlt;BRandgt;andlt;BRandgt;Psychopharmacological Treatmentandlt;BRandgt;andlt;BRandgt;Acute Treatment of Panic Disorderandlt;BRandgt;andlt;BRandgt;Continuation and Maintenance Treatment for Panic Disorderandlt;BRandgt;andlt;BRandgt;Social Phobiaandlt;BRandgt;andlt;BRandgt;Obsessive Compulsive Disorderandlt;BRandgt;andlt;BRandgt;Post-traumatic Stress Disorderandlt;BRandgt;andlt;BRandgt;Generalized Anxiety Disorderandlt;BRandgt;andlt;BRandgt;Continuation and Maintenanceandlt;BRandgt;andlt;BRandgt;Treatment of Generalized Anxietyandlt;BRandgt;andlt;BRandgt;Insomniaandlt;BRandgt;andlt;BRandgt;Diagnosisandlt;BRandgt;andlt;BRandgt;Treatmentandlt;BRandgt;andlt;BRandgt;andlt;Bandgt;5. Schizophrenia and Related Disordersandlt;/Bandgt;andlt;BRandgt;andlt;BRandgt;Diagnosisandlt;BRandgt;andlt;BRandgt;Subtypes of Schizophreniaandlt;BRandgt;andlt;BRandgt;Natural History, Epidemiology, and Geneticsandlt;BRandgt;andlt;BRandgt;Disorders Related to Schizophreniaandlt;BRandgt;andlt;BRandgt;Schizophreniform Disorderandlt;BRandgt;andlt;BRandgt;Schizoaffective Disorderandlt;BRandgt;andlt;BRandgt;Delusional Disorderandlt;BRandgt;andlt;BRandgt;Schizotypal Personality Disorderandlt;BRandgt;andlt;BRandgt;Medical Differential Diagnosisandlt;BRandgt;andlt;BRandgt;Laboratory Evaluationandlt;BRandgt;andlt;BRandgt;Psychiatric Differential Diagnosisandlt;BRandgt;andlt;BRandgt;Psychopharmacological Treatmentandlt;BRandgt;andlt;BRandgt;Psychopharmacological Treatment of Acute Schizophreniaandlt;BRandgt;andlt;BRandgt;Alternative Treatments of Acute Schizophreniaandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Acute Treatment of Schizoaffective Disorderandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Continuation Treatment of Acute Schizophreniaandlt;BRandgt;andlt;BRandgt;Maintenance Treatment of Schizophreniaandlt;BRandgt;andlt;BRandgt;Maintenance Treatment of Schizoaffective Disorderandlt;BRandgt;andlt;BRandgt;Treatment of Depression in Schizophreniaandlt;BRandgt;andlt;BRandgt;andlt;Bandgt;6. Disorders of Impulse Control: Eating Disorders, Drug and Alcohol Abuse, and Adult Attention Deficit/Hyperactivity Disorder (ADHD)andlt;/Bandgt;andlt;BRandgt;andlt;BRandgt;Eating Disordersandlt;BRandgt;andlt;BRandgt;Anorexia Nervosaandlt;BRandgt;andlt;BRandgt;Bulimia Nervosaandlt;BRandgt;andlt;BRandgt;Adult Attention Deficit/Hyperactivity Disorderandlt;BRandgt;andlt;BRandgt;Psychopharmacological Treatmentandlt;BRandgt;andlt;BRandgt;Alcohol and Drug Abuseandlt;BRandgt;andlt;BRandgt;Alcohol Abuseandlt;BRandgt;andlt;BRandgt;Cocaine Abuseandlt;BRandgt;andlt;BRandgt;Opiate Abuse (Heroin and Narcotic Analgesics)andlt;BRandgt;andlt;BRandgt;Other Drugsandlt;BRandgt;andlt;BRandgt;andlt;Bandgt;7. Personality Disordersandlt;/Bandgt;andlt;BRandgt;andlt;BRandgt;Diagnosisandlt;BRandgt;andlt;BRandgt;Subtypesandlt;BRandgt;andlt;BRandgt;Cluster A: Odd or Eccentric Personality Disordersandlt;BRandgt;andlt;BRandgt;Cluster B: Emotional or Chaotic Personality Disordersandlt;BRandgt;andlt;BRandgt;Cluster C: Anxious or Fearful Personality Disordersandlt;BRandgt;andlt;BRandgt;Natural History, Epidemiology, and Geneticsandlt;BRandgt;andlt;BRandgt;Psychopharmacological Treatment of Personality Disordersandlt;BRandgt;andlt;BRandgt;Conceptual Models of Pharmacotherapy: What Are We Treating?andlt;BRandgt;andlt;BRandgt;Psychopharmacological Treatment of Specific Personality Disordersandlt;BRandgt;andlt;BRandgt;Cluster A: Odd or Eccentric Personality Types Clusterandlt;BRandgt;andlt;BRandgt;B: Emotional or Chaotic Personality Types Clusterandlt;BRandgt;andlt;BRandgt;C: Anxious or Fearful Typesandlt;BRandgt;andlt;BRandgt;Depressive Spectrum Personality Disordersandlt;BRandgt;andlt;BRandgt;Management Issuesandlt;BRandgt;andlt;BRandgt;andlt;Bandgt;8. Treatment of Special Populations: Children/Adolescents, the Elderly, and Womenandlt;/Bandgt;andlt;BRandgt;andlt;BRandgt;Child and Adolescent Disordersandlt;BRandgt;andlt;BRandgt;Mood Disordersandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Diagnosisandlt;BRandgt;andlt;BRandgt;Pharmacotherapyandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Childhood Schizophreniaandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Diagnosisandlt;BRandgt;andlt;BRandgt;Pharmacotherapyandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Pervasive Developmental Disorders: Autistic Disorder, Asperger's Syndrome, and Related Entitiesandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Diagnosisandlt;BRandgt;andlt;BRandgt;Pharmacotherapyandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Anxiety Disordersandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Diagnosisandlt;BRandgt;andlt;BRandgt;Pharmacotherapyandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Attention Deficit/Hyperactivity Disorderandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Diagnosisandlt;BRandgt;andlt;BRandgt;Pharmacotherapyandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Sleep Disordersandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Diagnosisandlt;BRandgt;andlt;BRandgt;Pharmacotherapyandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Behavioral Conditionsandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Enuresisandlt;BRandgt;andlt;BRandgt;Conduct Disorderandlt;BRandgt;andlt;BRandgt;Aggressive, Destructive Behavior in Mentally Retarded Childrenandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Tourette's Disorderandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Diagnosisandlt;BRandgt;andlt;BRandgt;Pharmacotherapyandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Geriatric Disordersandlt;BRandgt;andlt;BRandgt;Pharmacotherapy for Common Disordersandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Mood Disordersandlt;BRandgt;andlt;BRandgt;Psychotic Disordersandlt;BRandgt;andlt;BRandgt;Anxiety Disorders and Insomniaandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Medications Used in Treating Dementiasandlt;BRandgt;andlt;BRandgt;Female-Specific Issues and Disordersandlt;BRandgt;andlt;BRandgt;Premenstrual Syndromeandlt;BRandgt;andlt;BRandgt;Medications During Pregnancyandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Antidepressantsandlt;BRandgt;andlt;BRandgt;Antianxiety Drugsandlt;BRandgt;andlt;BRandgt;Mood Stabilizersandlt;BRandgt;andlt;BRandgt;Antipsychoticsandlt;BRandgt;andlt;BRandgt;Electroconvulsive Treatmentandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Postpartum Period and Breastfeedingandlt;BRandgt;andlt;BRandgt;Menopauseandlt;BRandgt;andlt;BRandgt;SECTION FOURandlt;BRandgt;andlt;BRandgt;andlt;Bandgt;9. Antidepressantsandlt;/Bandgt;andlt;BRandgt;andlt;BRandgt;Historyandlt;BRandgt;andlt;BRandgt;Classificationandlt;BRandgt;andlt;BRandgt;Cyclic Antidepressantsandlt;BRandgt;andlt;BRandgt;Clinical Usesandlt;BRandgt;andlt;BRandgt;Biologic Effectsandlt;BRandgt;andlt;BRandgt;Choosing a Cyclic Antidepressantandlt;BRandgt;andlt;BRandgt;Antidepressant Classes: Prescribing Techniques and Side Effectsandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;General Principlesandlt;BRandgt;andlt;BRandgt;Selective Serotonin Reuptake Inhibitors (SSRIs)andlt;BRandgt;andlt;BRandgt;Novel Antidepressantsandlt;BRandgt;andlt;BRandgt;Tricyclic Antidepressants (and Related Compounds)andlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Monoamine Oxidase (MAO) Inhibitorsandlt;BRandgt;andlt;BRandgt;Clinical Usesandlt;BRandgt;andlt;BRandgt;Biologic Effectsandlt;BRandgt;andlt;BRandgt;Choice of Agents and Techniques for Prescribingandlt;BRandgt;andlt;BRandgt;Food and Drug Interactionsandlt;BRandgt;andlt;BRandgt;Other Side Effectsandlt;BRandgt;andlt;BRandgt;andlt;Bandgt;10. Lithium and Other Mood Stabilizersandlt;/Bandgt;andlt;BRandgt;andlt;BRandgt;Historyandlt;BRandgt;andlt;BRandgt;Lithiumandlt;BRandgt;andlt;BRandgt;Clinical Usesandlt;BRandgt;andlt;BRandgt;Biologic Effectsandlt;BRandgt;andlt;BRandgt;Techniques for Prescribingandlt;BRandgt;andlt;BRandgt;Side Effectsandlt;BRandgt;andlt;BRandgt;Lithium's Effects on Thyroid and Kidneysandlt;BRandgt;andlt;BRandgt;Lithium Toxicityandlt;BRandgt;andlt;BRandgt;Lithium Discontinuationandlt;BRandgt;andlt;BRandgt;Anticonvulsant Mood Stabilizersandlt;BRandgt;andlt;BRandgt;Carbamazepineandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Clinical Usesandlt;BRandgt;andlt;BRandgt;Biologic Effectsandlt;BRandgt;andlt;BRandgt;Techniques for Prescribingandlt;BRandgt;andlt;BRandgt;Side Effectsandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Valproateandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Clinical Usesandlt;BRandgt;andlt;BRandgt;Biologic Effectsandlt;BRandgt;andlt;BRandgt;Techniques for Prescribingandlt;BRandgt;andlt;BRandgt;Side Effectsandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;andlt;Bandgt;11. Antianxiety Medications and Hypnoticsandlt;/Bandgt;andlt;BRandgt;andlt;BRandgt;Historyandlt;BRandgt;andlt;BRandgt;Benzodiazepinesandlt;BRandgt;andlt;BRandgt;Clinical Usesandlt;BRandgt;andlt;BRandgt;Biologic Effectsandlt;BRandgt;andlt;BRandgt;Choosing a Benzodiazepineandlt;BRandgt;andlt;BRandgt;Techniques for Prescribingandlt;BRandgt;andlt;BRandgt;Benzodiazepine Withdrawalandlt;BRandgt;andlt;BRandgt;Other Side Effectsandlt;BRandgt;andlt;BRandgt;Zolpidem Buspironeandlt;BRandgt;andlt;BRandgt;Nonbarbiturate Sedatives and Hypnoticsandlt;BRandgt;andlt;BRandgt;Barbituratesandlt;BRandgt;andlt;BRandgt;L-Tryptophan and Melatoninandlt;BRandgt;andlt;BRandgt;Antihistaminesandlt;BRandgt;andlt;BRandgt;Clonidineandlt;BRandgt;andlt;BRandgt;Beta-blockersandlt;BRandgt;andlt;BRandgt;In the Futureandlt;BRandgt;andlt;BRandgt;andlt;Bandgt;12. Antipsychoticsandlt;/Bandgt;andlt;BRandgt;andlt;BRandgt;Historyandlt;BRandgt;andlt;BRandgt;Clinical Usesandlt;BRandgt;andlt;BRandgt;Biologic Effectsandlt;BRandgt;andlt;BRandgt;Choosing an Antipsychoticandlt;BRandgt;andlt;BRandgt;Atypical Antipsychoticsandlt;BRandgt;andlt;BRandgt;Techniques for Prescribingandlt;BRandgt;andlt;BRandgt;Side Effectsandlt;BRandgt;andlt;BRandgt;Acute Side Effectsandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;Dystonic Reactionsandlt;BRandgt;andlt;BRandgt;Akinesiaandlt;BRandgt;andlt;BRandgt;Akathisiaandlt;BRandgt;andlt;BRandgt;Neurolepticandlt;BRandgt;andlt;BRandgt;Malignant Syndromeandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Non-Neurological Side Effectsandlt;BRandgt;andlt;BRandgt;Tardive Dyskinesiaandlt;BRandgt;andlt;BRandgt;Antiparkinsonian Medicationsandlt;BRandgt;andlt;BRandgt;andlt;Bandgt;13. Electroconvulsive Therapy (ECT); Stimulantsandlt;/Bandgt;andlt;BRandgt;andlt;BRandgt;ECTandlt;BRandgt;andlt;BRandgt;Clinical Usesandlt;BRandgt;andlt;BRandgt;Mechanisms of Actionandlt;BRandgt;andlt;BRandgt;Techniques of Administrationandlt;BRandgt;andlt;BRandgt;Side Effectsandlt;BRandgt;andlt;BRandgt;Stimulantsandlt;BRandgt;andlt;BRandgt;Clinical Usesandlt;BRandgt;andlt;BRandgt;Mechanisms of Actionandlt;BRandgt;andlt;BRandgt;Techniques of Administrationandlt;BRandgt;andlt;BRandgt;Side Effectsandlt;BRandgt;andlt;BRandgt;SECTION FIVEandlt;BRandgt;andlt;BRandgt;andlt;Bandgt;14. The Split Treatment Model: Interactions Between Psychotherapy and Pharmacotherapyandlt;/Bandgt;andlt;BRandgt;andlt;BRandgt;Early Models, Early Problemsandlt;BRandgt;andlt;BRandgt;Psychotherapy/Pharmacotherapy Interactions: Theoretical Issuesandlt;BRandgt;andlt;BRandgt;Therapeutic Split Modelandlt;BRandgt;andlt;BRandgt;Advantages of the Split Modelandlt;BRandgt;andlt;BRandgt;Disadvantages of the Split Modelandlt;BRandgt;andlt;BRandgt;Psychodynamics of Psychopharmacologyandlt;BRandgt;andlt;BRandgt;Patient Educationandlt;BRandgt;andlt;BRandgt;Medication Compliance: Intra- and Interpersonal Factorsandlt;BRandgt;andlt;BRandgt;Technical Aspects of Split Treatmentandlt;BRandgt;andlt;BRandgt;Choosing a Psychopharmacologistandlt;BRandgt;andlt;BRandgt;Finding a Psychopharmacologist in Your Community or Groupandlt;BRandgt;andlt;BRandgt;The Consultation Processandlt;BRandgt;andlt;BRandgt;andlt;Iandgt;The Initial Consultationandlt;BRandgt;andlt;BRandgt;Working in an Ongoing Split Treatmentandlt;/Iandgt;andlt;BRandgt;andlt;BRandgt;Appendix: Psychiatric Medicationsandlt;BRandgt;andlt;BRandgt;Referencesandlt;BRandgt;andlt;BRandgt;Index